Perry Karsen joined Third Rock Ventures as a venture partner in 2016. He is a recognized leader in the development and growth of successful, product-driven biopharmaceutical companies.
- Board member of Jounce Therapeutics
- Board member of Nurix
- Board member of Pliant Therapeutics
- Board member of Voyager Therapeutics
Previously, Perry was the chief executive officer of Celgene Cellular Therapeutics from May, 2013 until his retirement from Celgene Corporation at the end of 2015. He held the position of executive vice president and chief operations officer at Celgene Corporation from July 2010 to May 2013 and he served as senior vice president and head of worldwide business development at Celgene and president of the Asia/Pacific Region, from May 2004 until February 2009. Perry was the president and CEO of Pearl Therapeutics, a privately held biotechnology company subsequently acquired by Astra-Zeneca, from February 2009 until July 2010. Earlier in his career, Perry held executive positions at Human Genome Sciences, Bristol-Myers Squibb, Genentech and Abbott Laboratories. He also was a general partner at Pequot Ventures from 2000-2003 focusing on investments in biotechnology and medical devices.
Perry has a B.S. in Biological Sciences from the University of Illinois, Urbana, an M.A. of Arts in Teaching Biology from Duke University, and a Masters of Management from the Kellogg School of Management at Northwestern University. Perry was appointed chairman of the board of directors for Intellia Therapeutics in 2016, and also serves on the boards of several privately and publicly held biotechnology companies, including OncoMed Pharmaceuticals and several Third Rock portfolio companies. He is currently on the board of the Biotechnology Innovation Organization (BIO) and is a past member of the board of directors of the Alliance for Regenerative Medicine (ARM). Perry is also on the boards of The Gladstone Foundation and the Sonoma Land Trust.
Perry showed up in costume for his kindergarten Halloween party one day before the school Halloween celebration.